Andrew Saik - Jun 10, 2025 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
MIST
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:19 PM
Previous filing
May 13, 2025
Next filing
Jun 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saik Andrew Director C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTREAL, QUEBEC, CANADA /s/ Jason Minio, Attorney-in-Fact 2025-06-12 0001616284

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Stock Option (right to buy) Award $0 +40K $0.00 40K Jun 10, 2025 Common Stock 40K $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.